I
Anti-Infective Pharmaceuticals Market - India September 2011
Executive Summary Market
Anti-infective pharmaceuticals market in India is valued at INR X bn in 20-Market is expected to grow at a CAGR of x% from 20---Anti infectives are the largest contributor to domestic sales, contributing around y%
Drivers: Drivers and Challenges
Challenges:
Increasing patient population Increasing number of vaccine approvals Increase in health insurances
Pricing pressure Logistic problems in the vaccine market
Introduction of new drugs
Drug regulation and patents
Competition
Strategic recommendations
Phases of clinical trial Approval and licensing of drugs Patents Highly fragmented market with large number of players Major foreign players in the market include Gilead inc, Abbott, Glaxosmithkline etc Major domestic companies include Ranbaxy, Cipla, Dr. Reddy’s, Sun Pharmaceuticals, Panacea Biotech, Torrent Pharmaceuticals among others Foray into the adult vaccine market Partnership with Governmental and private bodies
ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT
2
•Introduction •Market Overview •Drivers & Challenges •Government Initiatives •Drug Regulation and Patents •Competition •Strategic Recommendations
ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT
3
Indian anti-infectives market is expected to witness an enormous growth over the coming years Indian Market - Overview •Anti-infectives belong to the acute segment which makes up around z% of the total pharmaceutical industry Anti-infectives are the largest contributor to domestic pharmaceuticals sales, contributing around y%
Market Size and Growth INR bn 200 x%
150 100
Cephalosporins, penicillins and quinolones are key drug classes among anti-infectives, with a share of around z% of the country’s anti-infectives market
• Presently the market has a size of INR X bn, and is expected to grow at a CAGR of x% from 20----• In 2010 GSK’s Augmentin was the highest selling drug with sales of INR Y bn Zifi, Taxim ,Monocef, Mox, Taxim-O , Zinacef and Gerimac were the other top selling drugs
• India has emerged as one of the leading vaccine manufacturer in recent times, producing z% of the global health vaccines Pentaxim, Varivax and Prevenar were the top selling vaccines in 20--
x3 x2
x1
x4
x6
x5
50 2010
2011e
0 2012e
2013e
2014e
2015e
Top pharmaceutical segments - 2010 0
2
4
6
8
10
12
14
18 %
anti-infectives
1 y2
CVS gastro CNS
y
y
3
respiratory
yy4
diabetes pain oncology
16
5 y6 y8
y7
Source: ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT
4
Drivers & Challenges - Summary
Drivers
Challenges
Increasing patient population
Pricing pressure
Increasing number of vaccine approvals
Logistic problems in the vaccine market
Increase in health insurances Introduction of new drugs
ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT
5
Government Initiatives - Summary
Changes in tax structure
Control programmes
Government Initiatives
PPP Projects
Reduction in drug prices
ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT
6
Major domestic players in the market (1/9) Company Snapshot: Company 1 Corporate Information Headquarters
Location A
Founded
19--
Products Key People
Financial Performance Revenue INR bn
Revenue INR bn Profit / Loss 100 r1
Product 1, product 2
r2
Profit r4 r3
60 40
50
20
Person X- MD
0 2008
0 2009
2010
2011
Business Highlights • Employing around XX people, Company 1 is India’s largest pharmaceutical company, having manufacturing facilities in seven countries and serving customers in over YY countries • In June 20--, the company entered into an alliance with Company X to create an innovator and generic pharmaceuticals powerhouse • Company 1 launched anti-infectives such as Product 1 and Product 2 for the first time in India and is trying to promote the concept of product 3 on a local basis •Signed an agreement with Company X for manufacturing and marketing 3 new HIV/AIDS drugs in India and developing countries • Has been working on an anti-malaria research project since May 20-- to develop cheap anti malarial drugs Source: ANTI-INFECTIVE PHARMACEUTICAL MARKET INDIA 2011.PPT
7
For more detailed information kindly visit:
http://www.bharatbook.com/healthcare-market-research-reports/anti-infectiv
Bharat Book Bureau Phone : +91 22 27810772, 27810773 Fax : +91 22 27812290 E-mail : info@bharatbook.com Website : www.bharatbook.com